z-logo
open-access-imgOpen Access
Azithromycin and Loperamide Are Comparable to Levofloxacin and Loperamide for the Treatment of Traveler's Diarrhea in United States Military Personnel in Turkey
Author(s) -
John W. Sanders,
Robert W. Frenck,
Shan D. Putnam,
Mark S. Riddle,
James R. Johnston,
Sefa Ulukan,
David Rockabrand,
M. R. Monteville,
David R. Tribble
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/519264
Subject(s) - loperamide , azithromycin , levofloxacin , medicine , traveler's diarrhea , diarrhea , nausea , vomiting , adverse effect , antibacterial agent , randomized controlled trial , gastroenterology , antibiotics , microbiology and biotechnology , biology
The recommended treatment for traveler's diarrhea is the combination of an appropriate antibiotic (usually a fluoroquinolone) and loperamide. Azithromycin compared favorably with fluoroquinolones in trials that did not include the use of loperamide, but combination therapy has not, to our knowledge, been studied to date.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom